21 C.F.R. § 1.3 — Statute Treatment

Statute treatment: 21 C.F.R. § 1.3

Ranked leading cases interpreting this statute, drawn from 14 citation events across 11 distinct cases.
14citations total
11distinct interpreting cases
9distinct courts
0citations in last 5y
1957–2013year range
Top 11 leading cases
#1 Robert F. Bradley v. Caspar W. Weinberger, Secretary of Health, Education and Welfare (1973) ca1 65 own cites 3× in case
#2 Northern Trust Co. v. Upjohn Co. (1991) illappct 69 own cites 1× in case
#3 McNeil Pharmaceutical v. Hawkins (1996) dc 57 own cites 1× in case
#4 V. E. Irons, Inc. v. United States (1957) ca1 31 own cites 1× in case
#5 United States of America, Libelant-Appellee v. An Article of Device . . . Diapulse Manufacturing Corporation of America, Claimant-Appellant (1968) ca2 18 own cites 1× in case
#6 Cartwright v. Pfizer, Inc. (2005) txed 17 own cites 1× in case
#7 Mills v. Warner-Lambert Co. (2008) txed 17 own cites 1× in case
#8 SmithKline Beecham Consumer Healthcare, L.P. v. Watson Pharmaceuticals, Inc. (1999) nysd 11 own cites 1× in case
#9 Phelps v. Wyeth, Inc. (2012) ord 11 own cites 1× in case
#10 United States v. Diapulse Manufacturing Corp. of America (1967) ctd 4 own cites 2× in case
#11 Chatman v. Pfizer, Inc. (2013) mssd 7 own cites 1× in case

Ranking method: leading_score = ln(1 + own_citation_count) × √(mentions_in_case) × flag_factor, where flag_factor = 1.0 green · 0.6 unknown · 0.5 neutral · 0.4 yellow · 0.3 procedural · 0 red. Red-flagged cases excluded — their interpretation has been undermined and shouldn't lead the list. Top 20 returned per statute. Open any case for full G Cite, trajectory, and per-circuit treatment.